Intimation of demise of Mr. Nariman Medhora under Regulation 30 of SEBI (LODR) Reg, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fredun Pharmaceuticals has informed the stock exchanges about the sudden passing of Mr. Nariman Bamansha Medhora on 20th June 2025. He was a Promoter and Non-Executive Non-Independent Director, holding 7,19,815 shares representing 15.24% of the company's shareholding. He had been on the board since 30th September 2015 and contributed significantly to the company's leadership. As per SEBI LODR Regulation 31A(6)(c), he will cease to be part of the promoter/promoter group going forward. The remaining directors and employees have conveyed condolences to his family.
This is a sentimental and leadership loss rather than a financial one. The 15.24% promoter stake held by the deceased will need to be addressed through succession or transfer to legal heirs, which could lead to changes in promoter shareholding structure in the coming months. Short-term stock reaction may be negative on sentiment, but operations are unlikely to be materially affected as he held a non-executive role.